loading
前日終値:
$6.70
開ける:
$6.64
24時間の取引高:
3.10M
Relative Volume:
1.16
時価総額:
$2.06B
収益:
$493.67M
当期純損益:
$-104.69M
株価収益率:
-20.09
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
+4.92%
1か月 パフォーマンス:
-25.11%
6か月 パフォーマンス:
-42.94%
1年 パフォーマンス:
-35.26%
1日の値動き範囲:
Value
$6.63
$6.88
1週間の範囲:
Value
$6.325
$6.945
52週間の値動き範囲:
Value
$6.20
$12.65

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Name
名前
Amicus Therapeutics Inc
Name
セクター
Healthcare (1151)
Name
電話
(609) 662-2000
Name
住所
47 HULFISH STREET, PRINCETON, NJ
Name
職員
499
Name
Twitter
@amicusrx1
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
FOLD's Discussions on Twitter

FOLD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FOLD
Amicus Therapeutics Inc
6.83 2.06B 493.67M -104.69M -31.51M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-09-06 開始されました Jefferies Buy
2024-05-30 開始されました Wells Fargo Overweight
2024-05-14 アップグレード Guggenheim Neutral → Buy
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-04-13 再開されました Goldman Neutral
2022-01-14 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-15 アップグレード Stifel Hold → Buy
2021-09-30 アップグレード JP Morgan Neutral → Overweight
2021-07-19 再開されました BTIG Research Buy
2021-05-27 開始されました Needham Hold
2021-05-21 開始されました UBS Buy
2021-04-14 アップグレード Cantor Fitzgerald Neutral → Overweight
2021-03-02 開始されました Stifel Hold
2021-02-12 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-02-12 ダウングレード JP Morgan Overweight → Neutral
2020-12-28 再開されました Cantor Fitzgerald Overweight
2020-12-10 ダウングレード Citigroup Buy → Neutral
2020-11-11 開始されました Berenberg Hold
2020-06-17 開始されました BTIG Research Buy
2020-02-04 再開されました Cantor Fitzgerald Overweight
2019-11-12 繰り返されました H.C. Wainwright Buy
2019-06-17 開始されました H.C. Wainwright Buy
2019-06-05 繰り返されました Cantor Fitzgerald Overweight
2019-04-05 開始されました Janney Buy
2019-01-30 開始されました Cantor Fitzgerald Overweight
2018-10-29 開始されました Citigroup Neutral
2018-08-17 ダウングレード Chardan Capital Markets Buy → Neutral
2017-10-06 再開されました Goldman Neutral
2017-09-13 繰り返されました Chardan Capital Markets Buy
2017-08-10 繰り返されました Chardan Capital Markets Buy
2017-01-24 アップグレード Robert W. Baird Neutral → Outperform
2016-05-18 開始されました BofA/Merrill Buy
2016-04-14 開始されました Robert W. Baird Neutral
2016-04-12 繰り返されました Chardan Capital Markets Buy
2015-09-16 ダウングレード Chardan Capital Markets Buy → Neutral
2015-06-16 繰り返されました Chardan Capital Markets Buy
すべてを表示

Amicus Therapeutics Inc (FOLD) 最新ニュース

pulisher
Apr 18, 2025

Granite Investment Partners LLC Purchases 166,657 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 18, 2025
pulisher
Apr 18, 2025

Renaissance Technologies LLC Has $19.86 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 18, 2025
pulisher
Apr 17, 2025

4 Healthcare Stocks to Buy as the Sector Faces Government Heat - Yahoo Finance

Apr 17, 2025
pulisher
Apr 16, 2025

(FOLD) Proactive Strategies - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 14, 2025

Pompe Disease Treatment Market New Product Development & Latest Trends | Sanofi,Amicus Therapeutics,Genzym - openPR.com

Apr 14, 2025
pulisher
Apr 14, 2025

Enzyme Replacement Therapy Market Is Booming Worldwide - openPR.com

Apr 14, 2025
pulisher
Apr 14, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Down 6.3%Should You Sell? - MarketBeat

Apr 14, 2025
pulisher
Apr 12, 2025

Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowHere's What Happened - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

ExodusPoint Capital Management LP Sells 537,938 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Norges Bank Invests $29.03 Million in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 11, 2025
pulisher
Apr 11, 2025

Is ​​Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In? - Insider Monkey

Apr 11, 2025
pulisher
Apr 11, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st

Apr 11, 2025
pulisher
Apr 11, 2025

Massachusetts Financial Services Co. MA Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Fabry Disease Treatment Market Opportunity and Forecast Report 2025-2034 Featuring Amicus Therapeutics, Avrobio, Freeline, Idorsia, ISU Abxis, JCR, Novartis, Pfizer, Protalix, Sanofi, Takeda, Viatris - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Old West Investment Management LLC Grows Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 10, 2025
pulisher
Apr 09, 2025

Vanguard Group Inc. Has $275.62 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 09, 2025
pulisher
Apr 08, 2025

JPMorgan Chase & Co. Reduces Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 08, 2025
pulisher
Apr 08, 2025

Amicus Therapeutics stock hits 52-week low at $6.99 By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Amicus Therapeutics stock hits 52-week low at $6.99 - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires? - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

Research Analysts Issue Forecasts for FOLD Q1 Earnings - MarketBeat

Apr 08, 2025
pulisher
Apr 07, 2025

Trexquant Investment LP Acquires 486,827 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 07, 2025
pulisher
Apr 07, 2025

AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 07, 2025
pulisher
Apr 07, 2025

AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Zacks Research Analysts Increase Earnings Estimates for FOLD - MarketBeat

Apr 07, 2025
pulisher
Apr 07, 2025

Pictet Asset Management Holding SA Sells 110,241 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 07, 2025
pulisher
Apr 05, 2025

KLP Kapitalforvaltning AS Purchases New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 05, 2025
pulisher
Apr 04, 2025

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 52-Week LowHere's What Happened - MarketBeat

Apr 04, 2025
pulisher
Apr 03, 2025

Wellington Management Group LLP Buys 4,497,950 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Apr 03, 2025
pulisher
Apr 03, 2025

Brokerages Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Target Price at $16.75 - MarketBeat

Apr 03, 2025
pulisher
Apr 01, 2025

Relative Strength Alert For Amicus Therapeutics - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Amicus Therapeutics stock hits 52-week low at $8.09 - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Amicus Therapeutics stock hits 52-week low at $8.09 By Investing.com - Investing.com Australia

Apr 01, 2025

Amicus Therapeutics Inc (FOLD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):